Brief: Euroapi Plans To Invest In R&D Projects To Support Supply Of Essential Medicines To France, Europe
13/06/2023 13:06
June 13 (Reuters) - Euroapi SAS EAPI.PA :
* HEALTH SOVEREIGNTY: EUROAPI SUPPORTS THE SUPPLY OF
ESSENTIAL
MEDICINES TO FRANCE AND EUROPE
* ONCE RESEARCH AND DEVELOPMENT PROJECTS HAVE BEEN
SUCCESSFULLY
COMPLETED, EUROAPI PLANS FURTHER INVESTMENTS TO INCREASE ITS
PRODUCTION CAPACITY
* THESE INVESTMENTS WILL BE PARTIALLY FUNDED BY FRENCH STATE
VIA
FRANCE 2030
* TOTAL INVESTMENTS COULD REACH EUR 70 MILLION, OF WHICH
APPROXIMATELY 15% IN RESEARCH AND DEVELOPMENT AND 85% IN CAPEX,
THAT WOULD BE DEPLOYED FROM 2026
* AT THE CHEMICAL SYNTHESIS STAGE, EUROAPI PLANS TO INVEST
IN MORE
FLEXIBLE TECHNOLOGIES AND EQUIPMENT THAT WOULD ENHANCE
PRODUCTION CAPACITY BY 15% TO 20%
* THESE RESEARCH AND DEVELOPMENT ACTIVITIES AIM TO INCREASE
EUROAPI'S PRODUCTION OF MORPHINE AND ITS DERIVATIVES, AS WELL AS
THEIR ANTAGONISTS USED AS ANTIDOTES, BY 2027
Source text for Eikon: ID:nBw3xWc1Da
Further company coverage: EAPI.PA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48587696600;))